TY - JOUR
T1 - Sex-Related Differences in Genetic Cardiomyopathies
AU - Argirò, Alessia
AU - Ho, Carolyn
AU - Day, Sharlene M.
AU - van der Velden, Jolanda
AU - Cerbai, Elisabetta
AU - Saberi, Sara
AU - Tardiff, Jil C.
AU - Lakdawala, Neal K.
AU - Olivotto, Iacopo
N1 - Funding Information: Protein Mutations Leading to Familial Cardiomyopathy.” Dr van der Velden acknowledges support from NWO-ZoW (91818602 VICI grant), ZoW and Heart Foundation for the Translational Research Program, project 95105003; the Dutch Cardiovascular Alliance grant Double Dose 2021; and the Leducq Foundation grant number 20CVD01. Funding Information: Dr Olivotto was supported by the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No. 777204: “SILICOFCM - In Silico Trials for Drug Tracing the Effects of Sarcomeric Publisher Copyright: © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2022/5/3
Y1 - 2022/5/3
N2 - Cardiomyopathies are a heterogeneous collection of diseases that have in common primary functional and struc-tural abnormalities of the heart muscle, often genetically determined. The most effective categorization of cardiomyopathies is based on the presenting phenotype, with hypertrophic, dilated, arrhythmogenic, and restrictive cardiomyopathy as the proto-types. Sex modulates the prevalence, morpho-functional manifestations and clinical course of cardiomyopathies. Aspects as diverse as ion channel expression and left ventricular remodeling differ in male and female patients with myocardial disease, although the reasons for this are poorly understood. Moreover, clinical differences may also result from complex societal/en-vironmental discrepancies between sexes that may disadvantage women. This review provides a state-of-the-art appraisal of the influence of sex on cardiomyopathies, highlighting the many gaps in knowledge and open research questions.
AB - Cardiomyopathies are a heterogeneous collection of diseases that have in common primary functional and struc-tural abnormalities of the heart muscle, often genetically determined. The most effective categorization of cardiomyopathies is based on the presenting phenotype, with hypertrophic, dilated, arrhythmogenic, and restrictive cardiomyopathy as the proto-types. Sex modulates the prevalence, morpho-functional manifestations and clinical course of cardiomyopathies. Aspects as diverse as ion channel expression and left ventricular remodeling differ in male and female patients with myocardial disease, although the reasons for this are poorly understood. Moreover, clinical differences may also result from complex societal/en-vironmental discrepancies between sexes that may disadvantage women. This review provides a state-of-the-art appraisal of the influence of sex on cardiomyopathies, highlighting the many gaps in knowledge and open research questions.
KW - cardiomyopathies
KW - heart disease in women
KW - heart failure
UR - http://www.scopus.com/inward/record.url?scp=85129780753&partnerID=8YFLogxK
U2 - https://doi.org/10.1161/JAHA.121.024947
DO - https://doi.org/10.1161/JAHA.121.024947
M3 - Review article
C2 - 35470690
SN - 2047-9980
VL - 11
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 9
M1 - e024947
ER -